Genic Co (123330.KQ) Stock Price

Genic Co Price

CLOSED
15,470.00
​
Market closed

Revenue at Genic Co has contracted by 2.1% per year over the past 14 years to 78.20 B KRW. Earnings per share have grown at 2.3% per year over the last 14 years. For Genic Co, the net margin of 24.2% is up versus -11.3% a few years ago. The consensus 12-month price target for Genic Co is 42,840.00 KRW, about 176.9% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

Genic Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genic Co business model & stock analysis

Genic Co., Ltd. manufactures and sells cosmetics under brands such as Cel-Derma, Lasante, Puretree, and others. The company offers gel masks, essence masks, gel eye patches, self-heating masks, cleansers, basics, skin care products, makeup, hair care, perfumes, men cosmetics, body care, and manicures. It distributes its products domestically and internationally, targeting consumers seeking skincare, makeup, and personal care solutions through its branded product lines. The firm's revenue comes from selling its branded cosmetic products globally, with domestic and overseas markets as key sales channels. Customers purchase products under the Cel-Derma, Lasante, Puretree, and other brand names for skincare, makeup, hair care, and body care needs. Genic Co., Ltd. focuses on skincare and personal care segments, offering a wide range of products including masks, cleansers, makeup, and perfumes under its established brands. Its product portfolio serves both domestic and international consumer markets through direct sales and distribution networks.

Frequently asked questions about Genic Co

Analysts currently set an average price target of 42,840.00 KRW for the Genic Co stock (median: 42,840.00 KRW), implying +176.9 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the Genic Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Genic Co to generate revenue of 164.93 B KRW and earnings per share of 4,557.01 KRW.

Converted at the current exchange rate, the Genic Co share trades at 10.28 EUR (15,470.00 KRW).

The expected revenue of Genic Co is 164.93 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Genic Co is 35.66 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Genic Co is currently 3.39. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genic Co stock.

The price-to-sales ratio (P/S) of Genic Co is currently 0.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genic Co stock.

The Eulerpool Quality Score for Genic Co is 7/10.

The ISIN of Genic Co is KR7123330003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Genic Co is 123330.KQ. The ticker symbol is used to trade Genic Co shares on the stock exchange.

Fair ValueTerminal
14,851.20 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website genic21.com
Country
South Korea
Currency
KRW
Initial public offering
Aug 3, 2011
ISIN
KR7123330003
Cusip
Y2693Y106
Market capitalization
112.98 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
3.17
P/S
P/Se
0.73
EV/EBIT
7.54
P/B Ratio
2.75
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
46.01 %
Last updated Nov 3, 2026, 3:43 AM

Genic Co Peer Group

Genic Co FIGI

123330:KS · BBG001LVGMH1123330:KQ · BBG001R34SP8

All fundamentals and in-depth analysis of Genic Co

Our stock analysis for Genic Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genic Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.